Biomarker Discoveries in Gastric Precancerous Lesions

Offered By: Stanford Department of Medicine via YouTube

Course Description

Overview

Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!

Explore groundbreaking biomarker discoveries in gastric precancerous lesions in this 37-minute conference talk from the 2022 Gastric Cancer Summit. Presented by Dr. Constanza Camargo from The National Cancer Institute, delve into the Early Detection Research Network's findings on gastric cancer. Examine the roles of pepsinogen, inflammation, and H. pylori serology in early detection. Investigate multiplex studies combining pepsinogen and serology techniques. Uncover insights on genetic susceptibility, microRNAs, and methylation in gastric cancer development. Analyze trends, hypotheses, and key results that shape our understanding of gastric precancerous lesions. Gain valuable knowledge to advance gastric cancer research and early detection strategies.

Syllabus

Introduction
Early Detection Research Network
Gastric Cancer
Pepsinogen
Inflammation
Hpyloliserology
Multiplex studies
Pepsinogen and serology
Genetic susceptibility
MicroRNAs
Methylation
Trends
Hypothesis
Results
Key Concepts

Taught by

Stanford Department of Medicine

Related Courses

Strengthen internal and external audits of measles rubella laboratory performance in the South-East Asia Region (SEAR) network
OpenWHO Nursing Hygiene Training
Study.com Application of Molecular Methods in Diagnostic Microbiology - Dr. Alice Wort
The Royal College of Pathologists via YouTube Autoimmune Cholangiopathy and Pancreatitis - Alireza Sedarat, MD - UCLA Digestive Diseases
University of California, Los Angeles via YouTube Auto-Immune Hepatic and Biliary Disorders - Steven-Huy Han, MD - UCLA Digestive Disease
University of California, Los Angeles via YouTube